keyword
https://read.qxmd.com/read/37751242/feasibility-study-of-virtual-reality-based-cognitive-behavioral-therapy-for-patients-with-depression-protocol-for-an-open-trial-and-therapeutic-intervention
#41
JOURNAL ARTICLE
Ai Ito, Fumikazu Hiyoshi, Ayako Kanie, Azumi Maruyama, Mari S Oba, Shinsuke Kito
BACKGROUND: The clinical usefulness of cognitive behavioral therapy (CBT) for patients with depression who do not remit with pharmacotherapy has been recognized. However, the longer time burden on health care providers associated with conducting CBT and the lack of a system for providing CBT lead to inadequate CBT provision to patients who wish to receive it. OBJECTIVE: We aim to evaluate the feasibility of introducing virtual reality (VR) into CBT for patients with depression...
September 26, 2023: JMIR Research Protocols
https://read.qxmd.com/read/37750332/a-randomized-phase-ii-study-comparing-preoperative-mfolfox6-versus-folfoxiri-for-locally-advanced-colon-cancer-jcog2006
#42
REVIEW
Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, Atsuo Takashima, Tetsuya Hamaguchi, Yukihide Kanemitsu
The prognosis of locally advanced colon cancer (LACC) with surgical resection followed only by adjuvant chemotherapy is poor. Preoperative chemotherapy for LACC patients with risk factors such as cT4bN+ or cT3-4aN2-3 has attracted attention. Here, the authors describe the rationale and design of JCOG2006, a randomized phase II study comparing preoperative chemotherapy with mFOLFOX6 versus FOLFOXIRI for LACC. Their efficacy and safety are evaluated and a determination of which is the more promising treatment will be conducted in a subsequent phase III trial...
September 2023: Future Oncology
https://read.qxmd.com/read/37707296/effects-of-violet-excitation-light-emitting-diode-on-melatonin-secretion-and-sleepiness-preliminary-findings-from-a-randomized-controlled-trial
#43
JOURNAL ARTICLE
Katsuhiro Mitsui, Keigo Saeki, Mingyue Sun, Yuki Yamagami, Yoshiaki Tai, Kenji Obayashi
STUDY OBJECTIVES: A new-type lighting using violet-excitation light-emitting diodes (LED) with an action spectrum centered at approximately 405 nm was developed. Although violet-excitation LEDs can reduce melatonin suppression compared with blue-excitation LEDs, no studies have compared the effects of violet-excitation LEDs with those of blue-excitation LEDs on melatonin suppression. This study was designed to compare the effects of violet-excitation LEDs with those of blue-excitation LEDs on melatonin suppression, psychomotor vigilance, and sleepiness...
September 14, 2023: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/37673778/impact-of-providing-genetics-based-future-cardiovascular-risk-on-ldl-c-in-patients-with-familial-hypercholesterolemia
#44
JOURNAL ARTICLE
Akihiro Nomura, Hirofumi Okada, Atsushi Nohara, Masa-Aki Kawashiri, Masayuki Takamura, Hayato Tada
BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant monogenic disease characterized by high low-density lipoprotein cholesterol (LDL-C) levels. Although carrying causative FH variants is associated with coronary heart disease (CHD), it remains unclear whether disclosing its associated cardiovascular risk affects outcomes in patients with FH. OBJECTIVE: We aimed to evaluate the efficacy of providing future cardiovascular risk based on genetic testing in addition to a standard FH education program...
August 26, 2023: Journal of Clinical Lipidology
https://read.qxmd.com/read/37624623/efficacy-and-safety-of-the-smallpox-vaccine-for-postexposure-prophylaxis-in-monkeypox-protocol-for-an-open-labeled-single-armed-study
#45
JOURNAL ARTICLE
Rina Yano, Junko Terada-Hirashima, Yukari Uemura, Noriko Tomita, Yosuke Shimizu, Haruka Iwasaki, Nobumasa Okumura, Tetsuya Suzuki, Sho Saito, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari
BACKGROUND: In May 2022, a case of monkeypox (currently known as "mpox") with no history of overseas travel was reported in the United Kingdom, followed by reports of infections reported in Europe, the United States, and other countries worldwide. Due to the significant overlap in immune responses among viruses of the genus Orthopoxvirus (including smallpox virus, mpox virus, and vaccinia virus), it is believed that cross-immunity can be achieved by administering the smallpox virus vaccine...
August 25, 2023: JMIR Research Protocols
https://read.qxmd.com/read/37586958/ds-5670a-a-novel-mrna-encapsulated-lipid-nanoparticle-vaccine-against-severe-acute-respiratory-syndrome-coronavirus-2-results-from-a-phase-2-clinical-study
#46
RANDOMIZED CONTROLLED TRIAL
Kaoru Toyama, Takashi Eto, Kenji Takazawa, Shinji Shimizu, Tetsuo Nakayama, Kei Furihata, Yoshitaka Sogawa, Masafumi Kumazaki, Nao Jonai, Satoko Matsunaga, Fumihiko Takeshita, Kazutaka Yoshihara, Hitoshi Ishizuka
BACKGROUND: DS-5670a is a vaccine candidate for coronavirus disease 2019 (COVID-19) harnessing a novel modality composed of messenger ribonucleic acid (mRNA) encoding the receptor-binding domain (RBD) from the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encapsulated in lipid nanoparticles. Here, we report the safety, immunogenicity, and pharmacokinetic profile of DS-5670a from a phase 2 clinical trial in healthy adults who were immunologically naïve to SARS-CoV-2...
August 31, 2023: Vaccine
https://read.qxmd.com/read/37584156/phase-ii-biomarker-identification-study-of-anti-vegf-agents-with%C3%A2-folfiri-for-pretreated-metastatic-colorectal-cancer
#47
REVIEW
Tadayoshi Hashimoto, Satoshi Otsu, Shuichi Hironaka, Atsuo Takashima, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, Tetsuya Hamaguchi, Yukihide Kanemitsu
Chemotherapy plus antiangiogenic agents, including bevacizumab, ramucirumab and aflibercept, is a standard second-line treatment for patients with metastatic colorectal cancer, but which specific agents should be selected is ambiguous due to a lack of clear evidence from prospective studies. Previous reports have suggested ramucirumab and aflibercept could be more effective than bevacizumab in patients with high VEGF-D and high VEGF-A, respectively. JCOG2004 is a three-arm, randomized, phase II study to identify predictive biomarkers for these agents in patients who have failed first-line treatment...
August 16, 2023: Future Oncology
https://read.qxmd.com/read/37525257/rationale-and-design-of-an-investigator-initiated-multicenter-prospective-placebo-controlled-double-blind-randomized-trial-to-evaluate-the-effects-of-finerenone-on-vascular-stiffness-and-cardiorenal-biomarkers-in-type-2-diabetes-and-chronic-kidney-disease-five
#48
RANDOMIZED CONTROLLED TRIAL
Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, Hisako Yoshida, Motoaki Miyazono, Naohiko Takahashi, Daiju Fukuda, Yosuke Okada, Hiroki Teragawa, Satoru Suwa, Keisuke Kida, Masao Moroi, Isao Taguchi, Shigeru Toyoda, Michio Shimabukuro, Kengo Tanabe, Kenichi Tanaka, Masaomi Nangaku, Koichi Node
BACKGROUND: The overactivation of mineralocorticoid receptor (MR) plays a key pathological role in the progression of cardiovascular and renal diseases by promoting pro-inflammatory and pro-fibrotic signaling. Recently, it has been found that finerenone, a novel nonsteroidal selective MR antagonist, can robustly improve cardiorenal outcomes in patients with type 2 diabetes (T2D) and a wide spectrum of chronic kidney disease (CKD). However, the mechanisms underlying the cardiorenal benefits of finerenone are poorly understood...
July 31, 2023: Cardiovascular Diabetology
https://read.qxmd.com/read/37517127/distal-radial-approach-in-coronary-angiography-using-a-transdermal-nitroglycerin-patch-double-blinded-randomized-trial
#49
JOURNAL ARTICLE
Kota Murai, Masashi Fujino, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Hiroyuki Miura, Satoshi Honda, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yu Kataoka, Yasuhide Asaumi, Yoshio Tahara, Teruo Noguchi
Nitroglycerin dilates the radial artery and prevents spasm, which increases the success rate of sheath cannulation through the conventional transradial approach. However, the effects of nitroglycerin on distal radial approach (DRA) procedures are not known. The aim of this study is to elucidate whether a transdermal nitroglycerin patch improves the rate of successful DRA cannulation. A total of 92 patients scheduled for coronary angiography by means of DRA randomly received (1:1) a transdermal nitroglycerin patch preintegrated with the covering material or only the covering material on their upper arm on the side of the puncture...
July 28, 2023: American Journal of Cardiology
https://read.qxmd.com/read/37483483/mitigation-of-paclitaxel-induced-peripheral-neuropathy-in-breast-cancer-patients-using-limb-cooling-apparatus-a-study-protocol-for-a-randomized-controlled-trial
#50
JOURNAL ARTICLE
Chikako Funasaka, Akiko Hanai, Sadamoto Zenda, Keita Mori, Makoto Fukui, Nami Hirano, Rie Shinohara, Nozomu Fuse, Masashi Wakabayashi, Mai Itagaki, Yutaka Tomioka, Michihiko Nishina, Yasuaki Arai, Takahiro Kogawa, Yukinori Ozaki, Meiko Nishimura, Takayuki Kobayashi, Fumikata Hara, Toshimi Takano, Toru Mukohara
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common adverse events that can significantly impair the quality of life of patients. Although limb cooling may be beneficial for preventing CIPN, logistical challenges exist in ensuring consistent efficacy and safety. The purpose of this randomized controlled trial is to validate whether limb cooling with strict temperature control can reduce CIPN in patients with breast cancer receiving weekly paclitaxel as a perioperative treatment...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37403011/triple-modal-treatment-comprising-with-proton-beam-radiation-hyperthermia-and-gemcitabine-nab-paclitaxel-for-locally-advanced-pancreatic-cancer-a-phase-i-ii-study-protocol-tt-lap-trial
#51
JOURNAL ARTICLE
Osamu Shimomura, Masato Endo, Hirokazu Makishima, Takeshi Yamada, Shinji Hashimoto, Haruko Numajiri, Yoshihiro Miyazaki, Manami Doi, Kinji Furuya, Kazuhiro Takahashi, Toshikazu Moriwaki, Naoyuki Hasegawa, Yoshiyuki Yamamoto, Yusuke Niisato, Mariko Kobayashi, Masashi Mizumoto, Kei Nakai, Takashi Saito, Sodai Hoshiai, Tsukasa Saida, Bryan J Mathis, Kensaku Mori, Takahito Nakajima, Kiichiro Tsuchiya, Hideyuki Sakurai, Tatsuya Oda
BACKGROUND: Locally advanced pancreatic ductal adenocarcinoma (PDAC), accounting for about 30% of PDAC patients, is difficult to cure by radical resection or systemic chemotherapy alone. A multidisciplinary strategy is required and our TT-LAP trial aims to evaluate whether triple-modal treatment with proton beam therapy (PBT), hyperthermia, and gemcitabine plus nab-paclitaxel is a safe and synergistically effective treatment for patients with locally advanced PDAC. METHODS: This trial is an interventional, open-label, non-randomized, single-center, single-arm phase I/II clinical trial organized and sponsored by the University of Tsukuba...
July 4, 2023: BMC Cancer
https://read.qxmd.com/read/37371836/an-uncommon-cause-of-recurrent-presyncope-dizziness-and-tachycardia-a-case-report-of-diffuse-adult-onset-nesidioblastosis-non-insulinoma-pancreatogenous-hypoglycemia-syndrome-niphs
#52
Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, Hendrik Wiethoff, Albrecht Stenzinger, Manuel Röhrich, Uwe Pfeiffer, Wolfgang Rüdiger Kießling, Helena Engel, Harald Sourij, Thorsten Steinberg, Pascal Tomakidi, Stefan Kopf, Julia Szendroedi
Neurovegetative and autonomic symptoms are common presentations of various diseases, ranging from psychosomatic to severe organic disorders. A 23-year-old man presented with a history of recurrent presyncope, dizziness, and tachycardia. Repeated diagnostic work-up in various clinical settings could not identify any definite cause for approximately eight years. However, the incidental detection of postprandial and exercise-induced hypoglycemia was suggestive of an insulin-related disorder. A 72 h plasma glucose fasting test revealed endogenous hyperinsulinism...
June 17, 2023: Biomedicines
https://read.qxmd.com/read/37371827/diffuse-adult-onset-nesidioblastosis-non-insulinoma-pancreatogenous-hypoglycemia-syndrome-niphs-review-of-the-literature-of-a-rare-cause-of-hyperinsulinemic-hypoglycemia
#53
REVIEW
Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, Hendrik Wiethoff, Albrecht Stenzinger, Manuel Röhrich, Uwe Pfeiffer, Wolfgang Rüdiger Kießling, Helena Engel, Harald Sourij, Thorsten Steinberg, Pascal Tomakidi, Stefan Kopf, Julia Szendroedi
Differential diagnosis of hypoglycemia in the non-diabetic adult patient is complex and comprises various diseases, including endogenous hyperinsulinism caused by functional β-cell disorders. The latter is also designated as nesidioblastosis or non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS). Clinically, this rare disease presents with unspecific adrenergic and neuroglycopenic symptoms and is, therefore, often overlooked. A combination of careful clinical assessment, oral glucose tolerance testing, 72 h fasting, sectional and functional imaging, and invasive insulin measurements can lead to the correct diagnosis...
June 16, 2023: Biomedicines
https://read.qxmd.com/read/37337152/evaluation-of-clinical-effects-of-a-multidisciplinary-collaborated-cancer-support-team-for-gastrointestinal-cancer-chemotherapy-prospective-observational-study-protocol-of-m-cast-study
#54
JOURNAL ARTICLE
Yohei Iimura, Mitsuko Nakazawa, Yukari Tsuru, Hitomi Togashi, Tomoe Honda, Keisuke Baba, Masaaki Ishibashi, Chieko Sasuga, Naoki Furukawa, Tomoko Sato, Yasuo Matsubara, Ayako Kamisato, Eiko Yoshii, Seiichiro Kuroda, Narikazu Boku
BACKGROUND: Although the multidisciplinary-collaborated team approach in cancer treatment has recently become popular, prospectively evaluated evidence is limited. We started a multidisciplinary-collaborated cancer support team (MCST) to facilitate cooperation across multidisciplinary medical staff in our hospital and established clinical evidence of supportive care. This study aimed to prospectively evaluate the clinical activity and effect of MCST in patients with gastrointestinal cancer receiving chemotherapy...
June 19, 2023: BMC Gastroenterology
https://read.qxmd.com/read/37316381/study-design-and-rationale-for-marble-study-a-phase-ii-trial-of-atezolizumab-mpdl3280a-plus-carboplatin-and-paclitaxel-in-patients-with-advanced-or-recurrent-thymic-carcinoma-jtd2101
#55
JOURNAL ARTICLE
Tetsuhiko Asao, Takehito Shukuya, Tomoyasu Mimori, Yasushi Goto, Hiroshi Tanaka, Koichi Takayama, Yukari Tsubata, Motoko Tachihara, Takuji Suzuki, Kyoichi Kaira, Ryo Ko, Yoshitaka Zenke, Hiroaki Akamatsu, Junko Tanizaki, Satoshi Ikeda, Shunichi Sugawara, Hideaki Mizutani, Keita Mori, Kazuhisa Takahashi
BACKGROUND: Thymic carcinoma (TC) is a rare thymic epithelial tumor, and advanced or recurrent TC has limited prognosis. Treatment for chemotherapy-naïve, advanced, or recurrent TC remains unchanged with the combination of carboplatin and paclitaxel; therefore, a new treatment strategy is warranted. Immune checkpoint blockades inhibiting the programmed cell death-1 (PD-1) pathway (PD-1 and its ligand, PD-L1) have shown potential as a monotherapy for TC, although the efficacy of monotherapy was moderate for previously treated TC...
May 19, 2023: Clinical Lung Cancer
https://read.qxmd.com/read/37258074/preoperative-steroid-for-enhancing-patients-recovery-after-head-and-neck-cancer-surgery-with-free-tissue-transfer-reconstruction-protocol-for-a-phase-iii-placebo-controlled-randomised-double-blind-study-j-support-2022-preste-hn-study
#56
JOURNAL ARTICLE
Takeshi Shinozaki, Takayuki Imai, Kenya Kobayashi, Seiichi Yoshimoto, Sadamoto Zenda, Takuhiro Yamaguchi, Kohtaro Eguchi, Tomoka Okano, Tomoe Mashiko, Miyuki Kurosaki, Tempei Miyaji, Kazuto Matsuura
INTRODUCTION: There is no established methodology for the perioperative management of head and neck cancer surgery and free tissue transfer reconstruction (HNS-FTR). A single dose of corticosteroid administered immediately before surgery has been shown to reduce postoperative pain and nausea/vomiting after some types of surgery. However, the efficacy of this strategy has not been demonstrated in HNS-FTR, and the increased risk of infectious complications associated with its use cannot be ruled out...
May 31, 2023: BMJ Open
https://read.qxmd.com/read/37210524/lack-of-impact-of-ipragliflozin-on-endothelial-function-in-patients-with-type-2-diabetes-sub-analysis-of-the-protect-study
#57
JOURNAL ARTICLE
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, Kazuo Eguchi, Kazuo Fukumoto, Hirofumi Tomiyama, Koji Maemura, Atsushi Tanaka, Koichi Node
BACKGROUND: We assessed the impact of 24 months of treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on endothelial function in patients with type 2 diabetes as a sub-analysis of the PROTECT study. METHODS: In the PROTECT study, patients were randomized to receive either standard antihyperglycemic treatment (control group, n = 241 ) or add-on ipragliflozin treatment (ipragliflozin group, n = 241) in a 1:1 ratio. Among the 482 patients in the PROTECT study, flow-mediated vasodilation (FMD) was assessed in 32 patients in the control group and 26 patients in the ipragliflozin group before and after 24 months of treatment...
May 20, 2023: Cardiovascular Diabetology
https://read.qxmd.com/read/37205678/randomized-phase-ii-study-of-daily-versus-alternate-day-administrations-of-s-1-for-the-elderly-patients-with-completely-resected-pathological-stage-ia-tumor-diameter-2-cm-iiia-of-non-small-cell-lung-cancer-setouchi-lung-cancer-group-study-1201
#58
JOURNAL ARTICLE
Hiromasa Yamamoto, Junichi Soh, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenichi Gemba, Isao Sano, Takuji Fujinaga, Masafumi Kataoka, Yasuhiro Terazaki, Nobukazu Fujimoto, Kazuhiko Kataoka, Shinji Kosaka, Motohiro Yamashita, Hidetoshi Inokawa, Masaaki Inoue, Hiroshige Nakamura, Yoshinori Yamashita, Katsuyuki Hotta, Hiroshige Yoshioka, Satoshi Morita, Keitaro Matsuo, Junichi Sakamoto, Hiroshi Date, Shinichi Toyooka
BACKGROUND: It is shown that the postoperative adjuvant chemotherapy for non-small cell lung cancer (NSCLC) was associated with survival benefit in an elderly population. We aimed to analyze the feasibility and efficacy of alternate-day S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm) to IIIA (UICC TNM Classification of Malignant Tumours, 7th edition) NSCLC. METHODS: Elderly patients were randomly assigned to receive adjuvant chemotherapy for one year consisting of either alternate-day oral administration of S-1 (80 mg/m2/day) for 4 days a week (Arm A) or a daily oral administration of S-1 (80 mg/m2/day) for 14 consecutive days followed by 7-day rest (Arm B)...
2023: PloS One
https://read.qxmd.com/read/37195764/efficacy-and-safety-of-home-based-cardiac-telemonitoring-rehabilitation-in-patients-after-transcatheter-aortic-valve-implantation-single-center-usability-and-feasibility-study
#59
JOURNAL ARTICLE
Kohei Ashikaga, Shunichi Doi, Kihei Yoneyama, Norio Suzuki, Shingo Kuwata, Masashi Koga, Naoya Takeichi, Satoshi Watanabe, Masaki Izumo, Keisuke Kida, Yoshihiro J Akashi
BACKGROUND: No consensus exists on the efficacy of home-based cardiac rehabilitation (CR) in patients who have undergone transcatheter aortic valve implantation (TAVI). Additionally, there are no reports on home-based cardiac telemonitoring rehabilitation (HBTR) in patients after TAVI. OBJECTIVE: We aimed to investigate the efficacy of HBTR in patients who have undergone TAVI. METHODS: This single-center preliminary study introduced HBTR to patients after TAVI, and the efficacy outcomes of the rehabilitation method were compared to that of a historical control cohort...
May 17, 2023: JMIR Rehabilitation and Assistive Technologies
https://read.qxmd.com/read/37170203/behavioral-activation-for-depression-in-patients-with-advanced-cancer-study-protocol-for-a-multicenter-randomized-controlled-trial
#60
JOURNAL ARTICLE
Takatoshi Hirayama, Yuko Ogawa, Asao Ogawa, Emi Igarashi, Saaya Soejima, Kotone Hata, Yusuke Utsumi, Yuki Mashiko, Kyoka Ogata, Ayako Kayano, Yuko Yanai, Shin-Ichi Suzuki
BACKGROUND: Though behavioral activation (BA) has been shown to be effective for depression, evidence in patients with advanced cancer has not been established. This study aimed to examine the effectiveness of a BA program on depression in this population. METHODS: A randomized controlled trial with a wait-list control group (waiting group) of 38 patients with advanced cancer and depression will be conducted at three sites in Japan. The BA program consists of seven sessions...
May 11, 2023: BMC Cancer
keyword
keyword
116029
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.